Use of Noninvasive vs Invasive Ventilation for Patients Hospitalized With Acute Exacerbation of COPD, 2010 to 2019.
Allison V Lange, David B Bekelman, Lyndsay DeGroot and 2 others
PMID 40307172WHAT IT FOUND
Noninvasive ventilation use for COPD exacerbations nearly doubled from 2010 to 2019, rising from 6.2% to 10.9% of admissions.
This shift away from invasive ventilation coincided with lower mortality and shorter hospital stays, though it demands increased critical care nursing resources.
Key findings
01Risk-adjusted noninvasive ventilation (NIV) utilization increased from 6.2% in 2010 to 10.9% in 2019, while invasive mechanical ventilation (MV) use decreased from 6.0% to 4.5%.
02Hospital mortality for patients with acute exacerbation of COPD (AECOPD) decreased from 2.6% to 2.0%, and length of stay for survivors decreased from 5.4 to 4.4 days.
03Rates of NIV failure, defined as progression to invasive ventilation, decreased from 7.8% to 5.6% over the study period.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study relied on ICD billing codes, which may misclassify diagnoses and treatments. Physiologic data (e.g., blood gas values) were not available, so the study could not determine if NIV failure was due to patient condition or treatment limitations. The database did not contain information on staffing ratios or the specific unit (ICU vs. ward) where care was delivered, preventing analysis of how staffing affects outcomes. The study could not distinguish between NIV and high-flow nasal cannula (HFNC) in some cases due to billing code limitations prior to 2020, potentially overestimating NIV use. The association between NIV use and mortality is correlational, not causal.
Declared interests
The authors declared no conflicts of interest.
The easy way to misread this
Do not interpret the correlation between increased NIV use and decreased mortality as proof that NIV caused the improved outcomes. The study is observational and did not control for other concurrent changes in care, such as the potential misclassification of high-flow nasal cannula as NIV or improvements in general medical management.